FASLODEX

ਉਤਪਾਦ ਝਲਕ

About FASLODEX

FASLODEX is a prescription medication containing the active ingredient fulvestrant, used in the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following prior endocrine therapy.

Key Benefits & Uses

• Treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following prior endocrine therapy.
• Administered as an intramuscular injection, FASLODEX is a targeted therapy that works by depleting estrogen receptors in cancer cells.
• May be used in combination with other medications to treat breast cancer.

Active Ingredient & Action

FASLODEX contains the active ingredient fulvestrant, a selective estrogen receptor degrader (SERD) that works by binding to estrogen receptors in cancer cells and promoting their degradation. This action reduces the growth and spread of hormone receptor-positive breast cancer cells.

Important Notes

FASLODEX is available by prescription only and should be used under the guidance of a healthcare professional. Common side effects may include injection site reactions, nausea, and fatigue. Patients should inform their doctor of any medical history, including liver or kidney disease, and should not take FASLODEX if pregnant or breastfeeding.